Țaranu Adela
Main achievement
Head of Global Medical Affairs at Worwag Pharma GmbH
About
Adela Țaranu, a Doctor of Clinical Research and a graduate of the MBA LEAD program at Stanford Graduate School of Business, is a remarkable leader in the medical business field, with over a decade of experience in the pharmaceutical and medical device industries. She currently holds the position of Head of Global Medical Affairs at Wörwag Pharma GmbH & Co. KG, where she manages a diverse international team of medical advisors and writers, coordinating regulatory strategies, scientific documentation, and innovations for Rx products, OTC products, dietary supplements, and medical devices. Her career includes key roles such as Head of Global Medical Writing & Advice and Team Lead Global Regulatory Medical Writing within the same company, where she contributed to mitigating medical risks, obtaining market authorizations, and repositioning products, distinguishing herself through participation in international summits such as the Medical Affairs Excellence Summit in Prague. Her solid academic background, which began with a Bachelor's degree in Fundamental and Biomedical Sciences at Université Paris Cité, followed by a Master's degree in Pharmacology and Toxicology, was complemented by a Ph.D. in Clinical Research, with a focus on pharmacogenetics and bioengineering. Early professional experience included research internships at Inserm and AP-HP in Paris, collaborations with Servier Laboratoires for pharmacogenetic studies using whole exome sequencing, as well as positions as a medical scientific writer at Medtronic and NAMSA. At Wörwag Pharma, a German company founded in 1971 by Dr. Fritz Wörwag, specializing in biofactors for diabetic complications, neuropathies, and neurological conditions, Adela promotes scientific excellence, representing the company at global events and integrating innovative business perspectives gained at Stanford. Although details about Adela Țaranu's personal life remain private, her professional trajectory illustrates an exemplary dedication to health innovation, within an international context marked by Wörwag Pharma's expansion into over 35 countries. As a multilingual professional, she combines clinical expertise with strategic vision, contributing to the company's mission of providing superior quality solutions for the prevention and treatment of lifestyle-related conditions, thus inspiring generations of women in the medical field in Europe and beyond.
